Citation Impact
Citing Papers
Prediction of Pulmonary Complications and Long‐Term Survival in Systemic Sclerosis
2014
Regulatory T cells in autoimmune kidney diseases and transplantation
2023 StandoutNobel
Haemodynamic definitions and updated clinical classification of pulmonary hypertension
2018 Standout
Plasma Hsp90 levels in patients with systemic sclerosis and relation to lung and skin involvement: a cross-sectional and longitudinal study
2021 Standout
Adalimumab for long-term treatment of psoriatic arthritis: 2-year data from the Adalimumab Effectiveness in Psoriatic Arthritis Trial (ADEPT)
2008
Membrane vesicles, current state-of-the-art: emerging role of extracellular vesicles
2011 Standout
Certolizumab pegol in rheumatoid arthritis patients with low to moderate activity: the CERTAIN double-blind, randomised, placebo-controlled trial
2014
Evidence-based detection of pulmonary arterial hypertension in systemic sclerosis: the DETECT study
2013
Heterogeneity in Neutrophil Microparticles Reveals Distinct Proteome and Functional Properties
2013
Cancer treatment and survivorship statistics, 2022
2022 Standout
Systemic sclerosis-associated interstitial lung disease
2020
A review of the biological response to ionic dissolution products from bioactive glasses and glass-ceramics
2011 Standout
Idiopathic pulmonary fibrosis: effects and optimal management of comorbidities
2016
Rheumatoid arthritis
2018 Standout
Maintenance immunosuppression in myasthenia gravis
2016
Rheumatoid arthritis
2016 Standout
Synovial Tissue Inflammation Mediated by Autoimmune T Cells
2019 StandoutNobel
Neutrophils at work
2014 Standout
Type I interferon blockade in systemic lupus erythematosus: where do we stand?
2013
Increased levels of circulating microparticles in primary Sjögren's syndrome, systemic lupus erythematosus and rheumatoid arthritis and relation with disease activity
2009
Monitoring adverse events of low-dose glucocorticoid therapy: EULAR recommendations for clinical trials and daily practice
2010
Mechanisms of action of hydroxychloroquine and chloroquine: implications for rheumatology
2020 Standout
An official European Respiratory Society/American Thoracic Society research statement: interstitial pneumonia with autoimmune features
2015 Standout
Ultrasensitive Antibody Detection by Agglutination-PCR (ADAP)
2016 StandoutNobel
Modified-release sildenafil reduces Raynaud's phenomenon attack frequency in limited cutaneous systemic sclerosis
2011
Definitions and Diagnosis of Pulmonary Hypertension
2013 Standout
Emerging role of extracellular vesicles in inflammatory diseases
2014
Oral Glucocorticoid-Sparing Effect of Mepolizumab in Eosinophilic Asthma
2014 Standout
Incidence and predictors of cutaneous manifestations during the early course of systemic sclerosis: a 10-year longitudinal study from the EUSTAR database
2015
Macrophages in immunoregulation and therapeutics
2023 Standout
Exosomes: Extracellular organelles important in intercellular communication
2010 Standout
Systemic sclerosis
2022
Internet-based tapering of oral corticosteroids in severe asthma: a pragmatic randomised controlled trial
2011
Paediatric pulmonary arterial hypertension: updates on definition, classification, diagnostics and management
2018
Systemic sclerosis
2017 Standout
Curcumin as “Curecumin”: From kitchen to clinic
2007 Standout
The effect of biological agents on work participation in rheumatoid arthritis patients: a systematic review
2011
Pulmonary hypertension in chronic lung disease and hypoxia
2018
The role of microparticles in the pathogenesis of rheumatic diseases
2009
Single-specificity anti-Ku antibodies in an international cohort of 2140 systemic sclerosis subjects
2016
Low-Dose IL-2 Therapy in Autoimmune and Rheumatic Diseases
2021
The pathogenesis, diagnosis and treatment of Raynaud phenomenon
2012
Efficacy and safety of ustekinumab, an IL-12 and IL-23 inhibitor, in patients with active systemic lupus erythematosus: results of a multicentre, double-blind, phase 2, randomised, controlled study
2018
Rheumatoid arthritis therapy reappraisal: strategies, opportunities and challenges
2015
Idiopathic pulmonary fibrosis
2017 Standout
Measures of systemic sclerosis (scleroderma): Health Assessment Questionnaire (HAQ) and Scleroderma HAQ (SHAQ), Physician‐ and Patient‐Rated Global Assessments, Symptom Burden Index (SBI), University of California, Los Angeles, Scleroderma Clinical Trials Consortium Gastrointestinal Scale (UCLA SCTC GIT) 2.0, Baseline Dyspnea Index (BDI) and Transition Dyspnea Index (TDI) (Mahler's Index), Cambridge Pulmonary Hypertension Outcome Review (CAMPHOR), and Raynaud's Condition Score (RCS)
2011
Myasthenia gravis
2019 Standout
Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2010
2011 Standout
Autoantibodies as predictive tools in systemic sclerosis
2010
Adalimumab improves joint-related and skin-related functional impairment in patients with psoriatic arthritis: patient-reported outcomes of the Adalimumab Effectiveness in Psoriatic Arthritis Trial
2006
Efficacy and patient satisfaction in the use of subcutaneous immunoglobulin immunotherapy for the treatment of auto-immune neuromuscular diseases
2018
Decline of Mean Initial Prednisone Dosage From 10.3 to 3.6 mg/day to Treat Rheumatoid Arthritis Between 1980 and 2004 in One Clinical Setting, With Long‐Term Effectiveness of Dosages Less Than 5 mg/day
2012
Advances in the understanding and treatment of systemic complications in Sjögren's syndrome
2014
Evidence for treating rheumatoid arthritis to target: results of a systematic literature search update
2015
Classification, Functions, and Clinical Relevance of Extracellular Vesicles
2012 Standout
Major lung complications of systemic sclerosis
2018
Anti-inflammatory and immunoregulatory effects of paeoniflorin and total glucosides of paeony
2019 Standout
Immune checkpoint inhibitors: recent progress and potential biomarkers
2018 Standout
The incorporation of strontium and zinc into a calcium–silicon ceramic for bone tissue engineering
2010
Specificities of secretion and uptake of exosomes and other extracellular vesicles for cell-to-cell communication
2018 Standout
Epidemiology and clinical pattern of psoriatic arthritis in Germany: a prospective interdisciplinary epidemiological study of 1511 patients with plaque-type psoriasis
2009
Opportunities for Treg cell therapy for the treatment of human disease
2023 StandoutNobel
Pulmonary hypertension due to left heart disease
2018
Systemic sclerosis
2015
A guide to cancer immunotherapy: from T cell basic science to clinical practice
2020 Standout
Analysis of the prevalence of cataracts and glaucoma in systemic lupus erythematosus and evaluation of the rheumatologists' practice for the monitoring of glucocorticoid eye toxicity
2013
Health economic issues in rheumatoid arthritis
2006
High maternal expression of SIGLEC1 on monocytes as a surrogate marker of a type I interferon signature is a risk factor for the development of autoimmune congenital heart block
2017
The burden of rheumatoid arthritis and access to treatment: health burden and costs
2007
Dispensable roles of Gsdmd and Ripk3 in sustaining IL-1β production and chronic inflammation in Th17-mediated autoimmune arthritis
2021 StandoutNobel
Small RNAs are modified with N-glycans and displayed on the surface of living cells
2021 StandoutNobel
Consensus best practice pathway of the UK Scleroderma Study Group: digital vasculopathy in systemic sclerosis
2015
Nrf2 activation improves experimental rheumatoid arthritis
2023 StandoutNobel
Etiology, Risk Factors, and Biomarkers in Systemic Sclerosis with Interstitial Lung Disease
2019
Extracellular vesicles: Exosomes, microvesicles, and friends
2013 Standout
Nintedanib for Systemic Sclerosis–Associated Interstitial Lung Disease
2019 Standout
Proteomic comparison defines novel markers to characterize heterogeneous populations of extracellular vesicle subtypes
2016 Standout
Characterisation of fibroblast-like synoviocytes from a murine model of joint inflammation
2013
Bioactive Glass and Glass-Ceramic Scaffolds for Bone Tissue Engineering
2010 Standout
Psoriasis Pathogenesis and Treatment
2019 Standout
Strain-Specific Manifestation of Lupus-like Systemic Autoimmunity Caused by Zap70 Mutation
2019 StandoutNobel
Sarcoidosis-Associated Pulmonary Hypertension
2017
Overview of pharmacological activities ofAndrographis paniculataand its major compound andrographolide
2018 Standout
Correlation of the New York Heart Association Classification and the 6‐Minute Walk Distance: A Systematic Review
2015
Immune-Related Adverse Events Associated with Immune Checkpoint Blockade
2018 Standout
Effect of Impaired T Cell Receptor Signaling on the Gut Microbiota in a Mouse Model of Systemic Autoimmunity
2021 StandoutNobel
The Beneficial Effect of Total Glucosides of Paeony on Psoriatic Arthritis Links to Circulating Tregs and Th1 Cell Function
2013
Epitope specificity and significance in systemic autoimmune diseases
2010
Through the wall: extracellular vesicles in Gram-positive bacteria, mycobacteria and fungi
2015 Standout
Remission in rheumatoid arthritis: benefit over low disease activity in patient-reported outcomes and costs
2014
Cancer treatment and survivorship statistics, 2019
2019 Standout
Biomarker definitions and their applications
2018 Standout
An IL-2 mutein engineered to promote expansion of regulatory T cells arrests ongoing autoimmunity in mice
2020
Identification of Optimal Mouse Models of Systemic Sclerosis by Interspecies Comparative Genomics
2016
Differential Responsiveness of Monocyte and Macrophage Subsets to Interferon
2019
Standardization of sample collection, isolation and analysis methods in extracellular vesicle research
2013 Standout
Rationale for the evaluation of nintedanib as a treatment for systemic sclerosis–associated interstitial lung disease
2019
CAR T cell immunotherapy for human cancer
2018 StandoutScience
Cancer immunotherapy using checkpoint blockade
2018 StandoutScience
Impaired T cell receptor signaling and development of T cell–mediated autoimmune arthritis
2020 StandoutNobel
Role of Autoantibodies in the Diagnosis of Connective-Tissue Disease ILD (CTD-ILD) and Interstitial Pneumonia with Autoimmune Features (IPAF)
2017
Siglec‐1 and ‐2 as potential biomarkers in autoimmune disease
2016
Works of Dörte Huscher being referenced
Antibodies against PM/Scl-75 and PM/Scl-100 are independent markers for different subsets of systemic sclerosis patients
2009
Bronchoalveoloar lavage fluid cytokines and chemokines as markers and predictors for the outcome of interstitial lung disease in systemic sclerosis patients
2009
Pre-Capillary, Combined, and Post-Capillary Pulmonary Hypertension
2016
Six-minute walk distance as a marker for disability and complaints in patients with systemic sclerosis.
2011
Systemic sclerosis associated interstitial lung disease - individualized immunosuppressive therapy and course of lung function: results of the EUSTAR group
2018
Transgenic disruption of glucocorticoid signaling in mature osteoblasts and osteocytes attenuates K/BxN mouse serum–induced arthritis in vivo
2009
Prevalence and clinical associations of anti-Ku antibodies in patients with systemic sclerosis: a European EUSTAR-initiated multi-centre case–control study
2007
Low-dose interleukin-2 therapy in refractory systemic lupus erythematosus: an investigator-initiated, single-centre phase 1 and 2a clinical trial
2019
Effect of sildenafil on digital ulcers in systemic sclerosis: analysis from a single centre pilot study
2009
Diagnostic value of anti-topoisomerase I antibodies in a large monocentric cohort
2009
Expert consensus for performing right heart catheterisation for suspected pulmonary arterial hypertension in systemic sclerosis: a Delphi consensus study with cluster analysis
2013
Trends in treatment and outcomes of rheumatoid arthritis in Germany 1997–2007: results from the National Database of the German Collaborative Arthritis Centres
2010
IFNα and its response proteins, IP-10 and SIGLEC-1, are biomarkers of disease activity in systemic lupus erythematosus
2012
Dose-related patterns of glucocorticoid-induced side effects
2008
Defining appropriate outcome measures in pulmonary arterial hypertension related to systemic sclerosis: A Delphi consensus study with cluster analysis
2008
Progression of patients with Raynaud's phenomenon to systemic sclerosis: a five-year analysis of the European Scleroderma Trial and Research group multicentre, longitudinal registry study for Very Early Diagnosis of Systemic Sclerosis (VEDOSS)
2021
Treatment of Neurological Autoimmune Diseases with Immunoglobulins: First Insights from the Prospective SIGNS Registry
2012
The relationship between plasma microparticles and disease manifestations in patients with systemic sclerosis
2008
Mortality in pulmonary arterial hypertension: prediction by the 2015 European pulmonary hypertension guidelines risk stratification model
2017
Performance of the 2011 ACR/EULAR preliminary remission criteria compared with DAS28 remission in unselected patients with rheumatoid arthritis
2012
Pulmonary Hypertension in Patients with Chronic Fibrosing Idiopathic Interstitial Pneumonias
2015
Cost of illness in rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis and systemic lupus erythematosus in Germany
2006
Brief Report: Pulmonary Function Tests: High Rate of False‐Negative Results in the Early Detection and Screening of Scleroderma‐Related Interstitial Lung Disease
2015
OP0226 Expert consensus for performing right heart catheterization in suspicion of pulmonary arterial hypertension associated with systemic sclerosis: A delphi consensus study with cluster analysis from the eposs group
2012
Healthcare and burden of disease in psoriatic arthritis. A comparison with rheumatoid arthritis and ankylosing spondylitis.
2006
Employment across chronic inflammatory rheumatic diseases and comparison with the general population.
2005
Changes in referral, treatment and outcomes in patients with systemic lupus erythematosus in Germany in the 1990s and the 2000s
2014
Evaluation of Histologic, Serologic, and Clinical Changes in Response to Abatacept Treatment of Primary Sjögren's Syndrome: A Pilot Study
2013
FRI0377 High rate of false negatives in the early detection of interstitial lung disease associated with systemic sclerosis by pulmonary function tests
2013